Table 4.
Outcome | Rate of outcomes | aOR (95% CI) from model 1 | aOR (95% CI) from model 2 | aOR (95% CI) from model 3 | aOR (95% CI) from model 4 |
sICH | 414/48 141 (0.9) | ||||
Young adults | 26/5044 (0.5) | 0.57 (0.38 to 0.85) | 0.74 (0.49 to 1.11) | 0.77 (0.5 to 1.18) | 0.79 (0.52 to 1.20) |
Old adults | 388/43 097 (0.9) | 1.00 | 1.00 | 1.00 | 1.00 |
In-hospital mortality | 579/48 141 (1.2) | ||||
Young adults | 24/5044 (0.5) | 0.37 (0.24 to 0.55) | 0.54 (0.35 to 0.82) | 0.70 (0.46 to 1.09) | 0.65 (0.43 to 1.00) |
Old adults | 555/43 097 (1.3) | 1.00 | 1.00 | 1.00 | 1.00 |
Independent ambulation at discharge | 26 175/48 141 (54.4) | ||||
Young adults | 3079/5044 (61.0) | 1.36 (1.28 to 1.44) | 1.15 (1.08 to 1.22) | 1.00 (0.93 to 1.08) | 1.02 (0.96 to 1.10) |
Old adults | 23 096/43 097 (53.6) | 1.00 | 1.00 | 1.00 | 1.00 |
Model 1: logistic regression model without adjustment.
Model 2: adjusted for gender, insurance, BMI, previous stroke/TIA, previous CAD/prior MI, diabetes, hypertension, have smoking experience or behaviour, atrial fibrillation/flutter, glycated haemoglobin, diastolic blood pressure, systolic blood pressure, hypoglycaemic drugs, antihypertensive drugs, antiplatelet drugs and lipid-lowering drugs.
Model 3: adjusted for in-hospital NIHSS score, gender, insurance, BMI, previous stroke/TIA, previous CAD/prior MI, diabetes, hypertension, have smoking experience or behaviour, atrial fibrillation/flutter, glycated haemoglobin, diastolic blood pressure, blood pressure, hypoglycaemic drugs, antihypertensive drugs, antiplatelet drugs and lipid-lowering drugs. Patients (n=2503) with missing values on NIHSS score were not included in this analysis.
Model 4: results from multiple imputation.
aOR, adjusted OR; BMI, body mass index; CAD, coronary artery disease; MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial haemorrhage; IV tPA, intravenous tissue plasminogen activator.